EN
HI
Kabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
35925.00
Market Cap
59.22 CR
LTQ@LTP
1000@24.98
ATP
24.85
Var Margin
25 %
Circuit Range
22.32-27.26
Delivery %
92.7 %
Value
8.93 L
ASM/GSM
No
Market Lot
1
Summary
Kabra Drugs share price is ₹24.98 as of 15 May, 2026. The stock Kabra Drugs intraday movement has stayed between ₹24.06 and ₹25.99, while on a 52-week basis,Kabra Drugs price 52 week high is ₹35.52 & its 52 week low is ₹11.63.
In terms of trading activity, Kabra Drugs has recorded a volume of 35925 shares, The Kabra Drugs has a market cap of ₹23707850 CR. The stock’s Average Traded Price (ATP) stands at ₹24.85, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1000 @ ₹24.98.
Kabra Drugs operates within a circuit range of ₹22.32 – ₹27.26, with a Value of ₹8.93 L. The Delivery Percentage for the day is 92.7%. Additionally, Kabra Drugs currently falls under the No framework, and trades with a market lot size of 1.
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
67.24
Sector P/B
3.49
Sec. Div. Yield
0.56
Kabra Drugs Resistance and Support
Pivot 25.38
Resistance
First Resistance
26.2
Second Resistance
27.61
Third Resistance
28.43
Support
First Support
23.97
Second Support
23.15
Third Support
21.74
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-06 | Others |
| 2026-04-21 | Others |
| 2026-03-07 | Others |
| 2026-02-13 | Quarterly Results |
| 2025-11-28 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Kabra Drugs News
Kabra Drugs Ltd - 524322 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Kabra Drugs seeks shareholder approval for a major strategic shift, including renaming to Aanjaay Industries Limited and expanding its business scope to include drones, AI, EV components, and renewable energy. E-voting for these resolutions will be held from May 12, 2026, to June 10, 2026, with results by June 12, 2026.
May 08 2026 16:05:00
Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Kabra Drugs is strategically expanding its pharmaceutical manufacturing and entering the AI-driven defense technology sector. This includes a new R&D facility in Chennai and a key leadership appointment to drive growth.
May 06 2026 18:05:00
Read More
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| N Aravind | Managing Director |
| Kuniamuthur Nanjappan Anand | Executive Director |
Kabra Drugs Similar Stocks
Starsource Multitrade Ltd.
115.00
4.00 (3.60%)
Unjha Formulations Ltd.
20.11
0.21 (1.06%)
Ortin Global Ltd.
13.75
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
8.86
-0.33 (3.59%)
Dolphin Medical Services Ltd.
6.51
0.00 (0.00%)
Dhanvantri Jeevan Rekha Ltd.
19.53
-0.99 (4.82%)
Dr Lalchandani Labs Ltd.
9.67
0.46 (4.99%)
Transpact Enterprises Ltd.
200.00
0.00 (0.00%)
MPS Pharmaa Ltd.
1.73
0.00 (0.00%)
Decipher Labs Ltd.
7.50
0.27 (3.73%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 24.98 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 67.24 & 3.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 59.22 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 35.52 & 11.63. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.
